|
Group
|
G0-G1
|
G2-M
|
S
|
|---|
|
96 h Control
|
45.51 ± 13.52
|
8.51 ± 2.95
|
41.97 ± 16.47
|
|
Serum-free control
|
71.56 ± 5.60
|
8.16 ± 5.10
|
20.29 ± 10.71
|
|
SVPII 3 mg/L
|
41.22 ± 14.96 *
|
4.29 ± 2.70
|
54.47 ± 17.66 *
|
|
IL-3 10 μg/L
|
51.81 ± 18.23
|
3.11 ± 1.40
|
44.88 ± 19.87
|
- Cells were incubated in media containing 10% FCS + 62 μg/L rhM-CSF for 96 h (96 h control). All other cultures were treated with media plus rhM-CSF but without serum for 24 h and then treated for an additional 72 h with media supplemented with 10% FCS + 62 μg/L rhM-CSF (serum-free control) or treated with SVPII 3 mg/L or IL-3 10 μg/L in the same media. * P < 0.05 vs. serum-free control.
